findmyKOL

Oleg Krijanovski, MD, PhD

Basic profile

Alta Bates Summit Medical Center

ORCIDNone on fileNPI↗
✓ Full record
RegionBerkeley, CA · WestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Oleg Krijanovski is an Oncology physician affiliated with Alta Bates Summit Medical Center. OpenAlex indexes 34 publications with 1,577 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
34publications

Distinct works indexed by OpenAlex.

1,577citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
21companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2001 Dwight Way
Berkeley, CA 947042608

Telephone

510-204-1591

Provider last certified this registry record 7 Feb 2025.

View the NPPES registry record

Industry payments

21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    25.4%
    Kinase inhibitor11.8%
    Brukinsa27%Imbruvica19%Jakafi14%Tagrisso14%Calquence12%Imatinib Mesylate8%Gilotrif6%
    Part D<11 patients
    Thalidomide Analog6%
    Lenalidomide36%Pomalyst36%Revlimid28%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    16%
    Factor Xa inhibitor12.6%
    Eliquis71%Xarelto30%
    Part D≥23 patients
    Thrombopoietin Receptor Agonist2.6%
    Promacta100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    14.1%
    Serotonin-3 Receptor Antagonist3.5%
    Ondansetron Hcl59%Ondansetron Odt41%
    Part D≥18 patients
    Proton pump inhibitor3%
    Pantoprazole Sodium61%Omeprazole39%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)19.1% facility · 80.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”